Correlation between surgeon's assessment of residual disease and findings on postoperative pre-treatment computed tomography scan in women with advanced stage ovarian cancer reported to have undergone optimal cytoreduction: an NRG Oncology/GOG study

Eskander, Ramez

5
Correlation between surgeon's assessment of residual disease and findings on postoperative pre-treatment computed tomography scan in women with advanced stage ovarian cancer reported to have undergone optimal cytoreduction: an NRG Oncology/GOG study

Saturday, March 28, 2015: 8:55 AM

International Ballroom (Hilton Chicago)

R. N. Eskander¹, J. Kauderer², K. S. Tewari³, R. E. Bristow⁴ and R. A. Burger⁵
¹University of California at Irvine Medical Center, Orange, CA, ²Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, ³UC Irvine Medical Center, Orange, CA, ⁴University of California, Irvine, Irvine, CA, ⁵University of Pennsylvania, Philadelphia, PA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

5
Correlation between surgeon's assessment of residual disease and findings on postoperative pre-treatment computed tomography scan in women with advanced stage ovarian cancer reported to have undergone optimal cytoreduction: an NRG Oncology/GOG study

5 Correlation between surgeon's assessment of residual disease and findings on postoperative pre-treatment computed tomography scan in women with advanced stage ovarian cancer reported to have undergone optimal cytoreduction: an NRG Oncology/GOG study

5
Correlation between surgeon's assessment of residual disease and findings on postoperative pre-treatment computed tomography scan in women with advanced stage ovarian cancer reported to have undergone optimal cytoreduction: an NRG Oncology/GOG study